Abstract：
To evaluate the effect of a decision aid on decisional conflict scale in patients choosing management for early pregnancy loss.
We conducted a pilot randomized control trial to assess the effect of the Healthwise patient decision aid on decisional conflict scale in patients with early pregnancy loss as compared with a control website. Patients 18years and older were eligible if they had an early pregnancy loss between 5 and 12 completed weeks of gestation. Participants completed surveys at baseline, poststudy intervention, after consultation, and 1week postconsultation. Surveys assessed participant scores on the decisional conflict scale (scale 0-100), knowledge, assessment of shared decision-making, satisfaction, and decision regret. Our primary outcome was the poststudy-intervention decisional conflict scale score.
From July 2020 through March 2021 we randomized 60 participants. After the intervention, the median decisional conflict scale score for the control group was 10 [0-30] and 0 [0-20] for the intervention group (p = 0.17). When assessing the decisional conflict scale subscales postintervention, the informed subscale for the control group was 16.7 [0-33.3] as opposed to 0 [0] for the patient decision aid group (p = 0.003). Knowledge remained significantly higher in the experimental arm from the postintervention to the 1-week follow-up. We found no differences between groups when assessing our other metrics.
Use of a validated decision aid did not result in statistically significant differences in the total decisional conflict scale scores as compared with the control. Participants allocated to the intervention were more informed postintervention and had consistently higher knowledge scores.
Use of a validated decision aid prior to early pregnancy loss management consultation did not affect overall decisional conflict but resulted in improved knowledge.
We conducted a pilot randomized control trial to assess the effect of the Healthwise patient decision aid on decisional conflict scale in patients with early pregnancy loss as compared with a control website. Patients 18years and older were eligible if they had an early pregnancy loss between 5 and 12 completed weeks of gestation. Participants completed surveys at baseline, poststudy intervention, after consultation, and 1week postconsultation. Surveys assessed participant scores on the decisional conflict scale (scale 0-100), knowledge, assessment of shared decision-making, satisfaction, and decision regret. Our primary outcome was the poststudy-intervention decisional conflict scale score.
From July 2020 through March 2021 we randomized 60 participants. After the intervention, the median decisional conflict scale score for the control group was 10 [0-30] and 0 [0-20] for the intervention group (p = 0.17). When assessing the decisional conflict scale subscales postintervention, the informed subscale for the control group was 16.7 [0-33.3] as opposed to 0 [0] for the patient decision aid group (p = 0.003). Knowledge remained significantly higher in the experimental arm from the postintervention to the 1-week follow-up. We found no differences between groups when assessing our other metrics.
Use of a validated decision aid did not result in statistically significant differences in the total decisional conflict scale scores as compared with the control. Participants allocated to the intervention were more informed postintervention and had consistently higher knowledge scores.
Use of a validated decision aid prior to early pregnancy loss management consultation did not affect overall decisional conflict but resulted in improved knowledge.
摘要：
目的：评估决策帮助对决策冲突量表在患者选择早期妊娠丢失管理中的作用。
方法：我们进行了一项试点随机对照试验，以评估Healthwise患者决策辅助对早期妊娠丢失患者决策冲突量表与对照网站的影响。如果18岁及以上的患者在妊娠5至12周之间有早期妊娠损失，则符合资格。参与者在基线时完成调查，研究后干预,经过协商,咨询后1周。调查在决策冲突量表(量表0-100)上评估参与者得分，知识,共同决策的评估，满意,和后悔的决定。我们的主要结果是研究后干预决策冲突量表得分。
结果：从2020年7月到2021年3月，我们随机分配了60名参与者。干预之后,对照组的决策冲突量表评分中位数为10[0-30],干预组为0[0-20](p=0.17).在评估决策冲突量表干预后分量表时，对照组的知情子量表为16.7[0-33.3],而患者决策辅助组为0[0](p=0.003).从干预后到1周随访，实验组的知识仍然显着提高。在评估我们的其他指标时，我们没有发现组间的差异。
结论：与对照组相比，使用经过验证的决策辅助工具并未导致总决策冲突量表评分的统计学差异。分配给干预的参与者在干预后更加知情，并且知识得分始终较高。
结论：在早期妊娠丢失管理咨询之前使用经过验证的决策辅助不会影响整体决策冲突，但会提高知识水平。
方法：我们进行了一项试点随机对照试验，以评估Healthwise患者决策辅助对早期妊娠丢失患者决策冲突量表与对照网站的影响。如果18岁及以上的患者在妊娠5至12周之间有早期妊娠损失，则符合资格。参与者在基线时完成调查，研究后干预,经过协商,咨询后1周。调查在决策冲突量表(量表0-100)上评估参与者得分，知识,共同决策的评估，满意,和后悔的决定。我们的主要结果是研究后干预决策冲突量表得分。
结果：从2020年7月到2021年3月，我们随机分配了60名参与者。干预之后,对照组的决策冲突量表评分中位数为10[0-30],干预组为0[0-20](p=0.17).在评估决策冲突量表干预后分量表时，对照组的知情子量表为16.7[0-33.3],而患者决策辅助组为0[0](p=0.003).从干预后到1周随访，实验组的知识仍然显着提高。在评估我们的其他指标时，我们没有发现组间的差异。
结论：与对照组相比，使用经过验证的决策辅助工具并未导致总决策冲突量表评分的统计学差异。分配给干预的参与者在干预后更加知情，并且知识得分始终较高。
结论：在早期妊娠丢失管理咨询之前使用经过验证的决策辅助不会影响整体决策冲突，但会提高知识水平。
